Selective radiosensitization of 9L glioma in the brain transduced with double suicide fusion gene

Cancer Journal from Scientific American

Volumn 4, Issue 6, 1998, Pages 364-369

  Kim, Jae Ho ^a   Kolozsvary, Andrew ^a   Rogulski, Kenneth ^a   Khil, Mark S ^a   Brown, Stephen L ^a   Freytag, Svend O ^a  

^a HENRY FORD HOSPITAL   (United States)

Author keywords

Double suicide gene therapy; Glioma; Radiotherapy

Indexed keywords

FLUOROURACIL; GANCICLOVIR;

ANTINEOPLASTIC ACTIVITY; ARTICLE; BRAIN CANCER; CANCER RADIOTHERAPY; GENE THERAPY; GENE TRANSFER; GENETIC TRANSDUCTION; GLIOMA; NONHUMAN; PRIORITY JOURNAL; RADIOSENSITIZATION; RAT; SUICIDE GENE; TUMOR GROWTH; TUMOR VOLUME;

ANIMALS; ANTIMETABOLITES; BRAIN NEOPLASMS; ESCHERICHIA COLI; FLUCYTOSINE; GANCICLOVIR; GENE THERAPY; GENETIC VECTORS; GLIOMA; MALE; NUCLEOSIDE DEAMINASES; PRODRUGS; RADIATION-SENSITIZING AGENTS; RATS; RATS, INBRED F344; SIMPLEXVIRUS; THYMIDINE KINASE; TRANSDUCTION, GENETIC; TRANSFECTION;

EID: 0003303340     PISSN: 10814442     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Van Gilder JC, Berger M, Prados M et al. Gene therapy for the treatment of recurrent glioblastoma multiforme with in vivo tumor transduction with the HSV-tk gene/ganciclovir system. Human Gene Therapy Protocols 9303-037, NIH approval 04/16/93.
2. Crystal R, Hershowitz E, Lieberman M. A phase I study of direct administration of a replication-deficient adenovirus vector containing the E. coli cytosine deaminase gene to metastatic colon carcinoma of the liver in association with the oral administration of the prodrug 5-fluorocytosine. Human Gene Therapy Protocols 9509-125, NIH approval 09/30/95.
3. Kim JH, Kim SH, Brown SL et al. Selective enhancement by an antiviral agent of the radiation-induced cell killing of human glioma cells transduced with HSV-tk gene. Cancer Res 1994; 54:6053-6056.
4. Kim JH, Kim SH, Kolozsvary A et al. Selective enhancement of radiation response of herpes simplex virus thymidine kinase transduced 9L gliosarcoma cells in vitro and in vivo by antiviral agents. Int J Radiat Oncol Biol Phys 1995;33:861-868.
5. Khil M, Kim JH, Mullen CA et al. Radiosensitization by 5-fluorocytosine of human colorectal carcinoma cells in culture transduced with cytosine deaminase gene. Clin Cancer Res 1996;2:53-57.
6. Kim SH, Kim JH, Kolozsvary A et al. Preferential radiosensitization of 9L glioma cells transduced with HSV-TK gene by acyclovir. J Neurooncol 1997;33:189-195.
7. Gabel M, Kim JH, Kolozsvary A et al. Selective in vivo radiosensitization by 5- fluorocytosine of human colorectal carcinoma cells transduced with the E. coli cytosine deaminase (CD) gene. Int J Radiat Oncol Biol Phys 1998;41:883-887.
8. Rogulski KR, Kim JH, Kim SH et al. Glioma cells transduced with an E. coli CD/HSV-1 TK fusion gene exhibit enhanced metabolic suicide and radiosensitivity. Hum Gene Ther 1997; 8:73-85.
9. Kim JH, Alfieri A, Rosenblum M et al. Low dose rate radiotherapy for transplantable gliosarcoma in the rat brain. J Neurooncol 1990;9:9-15.
10. Freytag SO, Paielli DL, Gilbert JD. Ectopic expression of the CCAAT/enhancer binding protein a promotes the adipogenic program in a variety of mouse fibroblastic cells. Genes Dev 1994;14:1654-1663.
11. Rogulski K, Zhang K, Kolozsvary A et al. Pronounced antitumor effects and tumor radiosensitization of double suicide gene therapy. Clin Cancer Res 1997;3:2081-2088.
12. Aghi M, Kramm CM, Chou TC et al. Synergistic anticancer effects of ganciclovir/thymidine kinase plus 5-fluorocytosine/cytosine deaminase gene therapies. J Natl Cancer Inst 1998;90:370-380.
13. Uckert W, Kammertons T, Haack K et al. Double suicide gene (cytosine deaminase and herpes simplex virus thymidine kinase) but not single gene transfer allows reliable elimination of tumor cells in vivo. Hum Gene Ther 1998;9:855-865.
14. McGinn CJ, Miller EM, Lindstrom MJ et al. The role of cell cycle redistribution in radiosensitization: implications regarding the mechanism of fluorodeoxyuridine radiosensitization. Int J Radiat Oncol Biol Phys 1994;30:851-859.
15. McGinn CJ, Shewach DS, Lawrence TS. Radiosensitizing nucleosides. J Natl Cancer Inst 1996;88:1193-1203.
16. Kim JH, Alfieri AA, Kim SH et al. The potentiation of radiation response on murine tumor by fludarabine phosphate. Cancer Lett 1986;31:69-76.
17. Chen SH, Shine HD, Goodman JC et al. Gene therapy for brain tumors: regression of experimental gliomas by adenovirus-mediated gene transfer in vivo. Proc Natl Acad Sci USA 1994;91:3054-3057.
18. Hirschowitz EA, Ohwada A, Pascal WR et al. In vivo adenovirus-mediated gene transfer of the Escherichia coli cytosine deaminase gene to human colon carcinoma-derived tumors induces chemosensitivity to 5-fluorocytosine. Hum Gene Ther 1995; 6:1055-1063.
19. Dong Y, Wen P, Manome Y et al. In vivo replication-deficient adenovirus vector-mediated transduction of the cytosine deaminase gene sensitizes glioma cells to 5-fluorocytosine. Hum Gene Ther 1996;7:713-720.
20. Ohwada A, Hirschowitz EA, Crystal RG. Regional delivery of an adenovirus vector containing the E. coli cytosine deaminase gene to provide local activation of 5-fluorocytosine to suppress the growth of colon carcinoma metastatic to liver. Hum Gene Ther 1996;7:1567-1576.
21. Bischoff JR, Kiru DH, Williams A et al. An adenovirus mutant that replicates selectively in p-53-deficient human tumor cells. Science 1996;274:373-376.
22. Heise C, Sampson-Johannes A, Williams A et al. ONYX-015, an E1B gene-attenuated adenovirus, causes tumor specific cytolysis and antitumor efficacy that can be augmented by standard chemotherapeutic agents. Nat Med 1997;3:639-645.
23. Freytag SO, Rogulski KR, Paielli DL et al. A novel, three-pronged approach to selectively kill cancer cells: concomitant double suicide gene, viral, and radiotherapy. Hum Gene Ther 1998;9:1323-1333.